Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads

被引:37
作者
Hauser, RG
Cannom, D
Hayes, DL
Parsonnet, V
Hayes, J
Ratliff, N
Tyers, GFO
Epstein, AE
Vlay, SC
Furman, S
Gross, J
机构
[1] Minneapolis Heart Inst Fdn, Minneapolis, MN USA
[2] Good Samaritan Hosp, Los Angeles, CA USA
[3] Mayo Clin, Rochester, MN USA
[4] Newark Beth Israel, Newark, NJ USA
[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Hosp Stony Brook, Stony Brook, NY USA
[9] Montefiore Med Ctr, Bronx, NY 10467 USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2002年 / 25卷 / 06期
关键词
implantable cardioverter defibrillator; leads; complications; registry;
D O I
10.1046/j.1460-9592.2002.t01-1-00879.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transvene models 693616966, a coaxial polyurethane ICD lead, may be prone to structural failure. These models comprise 54% of ICD lead failures in the authors' Multicenter Registry database. Because ICD leads perform a vital function, the clinical features, causes, and probability of Transvene 693616966 lead failure were determined. The Registry and United States Food and Drug Administration databases were queried for the clinical features and structural causes of the Transvene 693616966 lead failure, and a five-center substudy estimated the survival probability for 521 Transvene 6936/6966 implants. The mean time to failure was 4.8 +/- 2.1 years, and the estimated survival at 60 and 84 months after implant were 92% and 84%, respectively. Oversensing was the most common sign of failure (76%), and 24 patients experienced inappropriate shocks. The manufacturer's reports indicated that high voltage coil fracture and 80A polyurethane defects were the predominant causes of lead failure. Transvene models 6936 and 6966 coaxial polyurethane ICD leads are prone to failure over time. Patients who have these leads should be evaluated frequently, Additional studies are needed to identify safe management strategies.
引用
收藏
页码:879 / 882
页数:4
相关论文
共 50 条
  • [21] Long-term longevity and clinical outcomes of Linox S/SD implantable cardioverter-defibrillator leads: a single-center experience
    Mohammad Alasti
    Colin Machado
    Sam Mirzaee
    Stewart Healy
    Logan Bittinger
    David Adam
    Emily Kotschet
    Jack Krafchek
    Jeffrey Alison
    Journal of Interventional Cardiac Electrophysiology, 2021, 61 : 115 - 121
  • [22] Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients
    van Welsenes, Guido H.
    van Rees, Johannes B.
    Borleffs, C. Jan Willem
    Cannegieter, Suzanne C.
    Bax, Jeroen J.
    van Erven, Lieselot
    Schalij, Martin J.
    EUROPACE, 2011, 13 (03): : 389 - 394
  • [23] Implantable Cardioverter-Defibrillator Therapy: Influence of Left Ventricular Function on Long-Term Results
    Pitschner H.F.
    Neuzner J.
    Himmrich E.
    Liebrich A.
    Jung J.
    Heisel A.
    Journal of Interventional Cardiac Electrophysiology, 1997, 1 (3) : 211 - 220
  • [24] Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads
    Burri, Haran
    Combescure, Christophe
    EUROPACE, 2014, 16 (08): : 1210 - 1217
  • [25] Long-term outcomes of heart failure patients who received primary prevention implantable cardioverter-defibrillator: An observational study
    Looi, Khang-Li
    Sidhu, Karishma
    Cooper, Lisa
    Dawson, Liane
    Slipper, Debbie
    Gavin, Andrew
    Lever, Nigel
    JOURNAL OF ARRHYTHMIA, 2018, 34 (01) : 46 - 54
  • [26] Long-term Arrhythmia Variability after Monomorphic Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator
    Clemens, Marcell
    Nagy-Balo, Edina
    Herczku, Csaba
    Kun, Csaba
    Edes, Istvan
    Csanadi, Zoltan
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (10): : 1185 - 1191
  • [27] Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians' survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry
    Biffi, Mauro
    Menardi, Endrj
    Narducci, Maria L.
    Ammendola, Ernesto
    Messano, Loredana
    Giofre, Fabrizio
    Baiocchi, Claudia
    Saporito, Davide
    Lissoni, Fabio
    Bertini, Matteo
    Pierantozzi, Attilio
    Zingarini, Gianluca
    Malacrida, Maurizio
    Ziacchi, Matteo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2017, 18 (12) : 968 - 975
  • [28] Insulation Defects in Riata Implantable Cardioverter-defibrillator Leads
    Sato, Akinori
    Chinushi, Masaomi
    Iijima, Kenichi
    Izumi, Daisuke
    Furushima, Hiroshi
    INTERNAL MEDICINE, 2012, 51 (19) : 2689 - 2694
  • [29] AutoCapture with dual-coil leads of implantable cardioverter defibrillator
    Acosta, H
    Massumi, A
    Malik, R
    Ahmad, S
    Antonio, C
    Syed, ZA
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 : S267 - S269
  • [30] Do abandoned leads pose risk to implantable cardioverter-defibrillator patents?
    Glikson, Michael
    Suleiman, Mahmoud
    Luria, David M.
    Martin, Marjorie L.
    Hodge, David O.
    Shen, Win-Kuang
    Bradley, David J.
    Munger, Thomas M.
    Rea, Robert F.
    Hayes, David L.
    Hammill, Stephen C.
    Friedman, Paul A.
    HEART RHYTHM, 2009, 6 (01) : 65 - 68